Yuval Shaked

Yuval Shaked is a dedicated professional aiming to unveil host response effects to cancer therapy with the intent to innovate new cancer treatment methods when combined with conventional therapies.

With a background in Mathematics and Physics from Katzenelson High School in Kfar Saba, Israel, Yuval Shaked brings a unique perspective to his work in the field of cancer research.

Yuval has an extensive history of leadership roles in various organizations including Chief Scientific Advisor and Co-Founder at OncoHost, Co-Founder and CSA of RemedyCell at RemedyCel, Chief Scientific Advisor at OncoHost, and other vital positions.

Yuval Shaked's expertise and dedication have led to the discovery of over 30 new cancer targets through the host response approach, which are currently undergoing preclinical testing for their efficacy in cancer treatment.

His professional journey includes a significant tenure as a Professor at Technion - Israel Institute of Technology, a Postdoctoral Fellow at Sunnybrook Health Sciences Centre, and a PhD student at Hebrew University of Jerusalem.